181 related articles for article (PubMed ID: 35227052)
1. Determination of the Phototoxicity Potential of Commercially Available Tattoo Inks Using the 3T3-neutral Red Uptake Phototoxicity Test.
Utku Türk EG; Jannuzzi AT; Alpertunga B
Turk J Pharm Sci; 2022 Feb; 19(1):70-75. PubMed ID: 35227052
[TBL] [Abstract][Full Text] [Related]
2. A Study on UV Filter Chemicals from Annex VII of European Union Directive 76/768/EEC, in the In Vitro 3T3 NRU Phototoxicity Test.
Spielmann H; Balls M; Dupuis J; Pape WJ; de Silva O; Holzhütter HG; Gerberick F; Liebsch M; Lovell WW; Pfannenbecker U
Altern Lab Anim; 1998; 26(5):679-708. PubMed ID: 26042493
[TBL] [Abstract][Full Text] [Related]
3. The International EU/COLIPA In Vitro Phototoxicity Validation Study: Results of Phase II (Blind Trial). Part 1: The 3T3 NRU Phototoxicity Test.
Spielmann H; Balls M; Dupuis J; Pape WJ; Pechovitch G; de Silva O; Holzhütter HG; Clothier R; Desolle P; Gerberick F; Liebsch M; Lovell WW; Maurer T; Pfannenbecker U; Potthast JM; Csato M; Sladowski D; Steiling W; Brantom P
Toxicol In Vitro; 1998 Jun; 12(3):305-27. PubMed ID: 20654413
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of phototoxicity of tattoo pigments using the 3 T3 neutral red uptake phototoxicity test and a 3D human reconstructed skin model.
Kim SY; Seo S; Choi KH; Yun J
Toxicol In Vitro; 2020 Jun; 65():104813. PubMed ID: 32119999
[TBL] [Abstract][Full Text] [Related]
5. [The establishment and assessment on cosmetic products using 3T3 mouse fibroblast neutral red uptake phototoxicity assay].
Yang Y; Xiong XK; Yang XF; He XW; Huang JM; Tan XH; Zheng SS
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Nov; 41(6):479-82. PubMed ID: 18399129
[TBL] [Abstract][Full Text] [Related]
6. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
Ceridono M; Tellner P; Bauer D; Barroso J; Alépée N; Corvi R; De Smedt A; Fellows MD; Gibbs NK; Heisler E; Jacobs A; Jirova D; Jones D; Kandárová H; Kasper P; Akunda JK; Krul C; Learn D; Liebsch M; Lynch AM; Muster W; Nakamura K; Nash JF; Pfannenbecker U; Phillips G; Robles C; Rogiers V; Van De Water F; Liminga UW; Vohr HW; Wattrelos O; Woods J; Zuang V; Kreysa J; Wilcox P
Regul Toxicol Pharmacol; 2012 Aug; 63(3):480-8. PubMed ID: 22687423
[TBL] [Abstract][Full Text] [Related]
7. An in vitro phototoxicity assay battery (photohaemolysis and 3T3 NRU PT test) to assess phototoxic potential of fragrances.
Nam C; An S; Lee E; Moon S; Kang J; Chang I
Altern Lab Anim; 2004 Jun; 32 Suppl 1B():693-7. PubMed ID: 23581161
[TBL] [Abstract][Full Text] [Related]
8. Formaldehyde Release From Predispersed Tattoo Inks: Analysis Using the Chromotropic Acid Method.
Liou YL; Voller LM; Liszewski W; Ericson ME; Siegel PD; Warshaw EM
Dermatitis; 2021 Sep-Oct 01; 32(5):327-332. PubMed ID: 33273225
[TBL] [Abstract][Full Text] [Related]
9. Tattoo Ink Market in France: A Field Study among 598 Professional Tattooists.
Kluger N
Dermatology; 2022; 238(6):1146-1151. PubMed ID: 35533664
[TBL] [Abstract][Full Text] [Related]
10. Tattoo inks: evaluation of cellular responses and analysis of some trace metals.
Sozer Karadagli S; Kaftan G; Cansever I; Armagan G; Sogut O
Biometals; 2024 Apr; 37(2):495-505. PubMed ID: 38038794
[TBL] [Abstract][Full Text] [Related]
11. A new high-throughput method to make a quality control on tattoo inks.
Persechino S; Toniolo C; Ciccola A; Serafini I; Tammaro A; Postorino P; Persechino F; Serafini M
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jan; 206():547-551. PubMed ID: 30179798
[TBL] [Abstract][Full Text] [Related]
12. Absence of phototoxicity/photoirritation potential of bergamottin determined In Vitro using OECD TG 432.
Cluzel M; Hais G; Irizar A; Lenouvel V; Nash JF; Penichot C; Sauvage C; Vey M; Wolf N
Regul Toxicol Pharmacol; 2022 Dec; 136():105281. PubMed ID: 36288771
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the skin sensitization potential of 3 red and 2 black tattoo inks using interleukin-18 as a biomarker in a reconstructed human skin model.
Bil W; van der Bent SAS; Spiekstra SW; Nazmi K; Rustemeyer T; Gibbs S
Contact Dermatitis; 2018 Dec; 79(6):336-345. PubMed ID: 30136287
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the phototoxicity induced by BRAF inhibitors and alleviation through antioxidants.
Heppt MV; Clanner-Engelshofen BM; Marsela E; Wessely A; Kammerbauer C; Przybilla B; French LE; Berking C; Reinholz M
Photodermatol Photoimmunol Photomed; 2020 Mar; 36(2):126-134. PubMed ID: 31618797
[TBL] [Abstract][Full Text] [Related]
15. Black tattoo inks induce reactive oxygen species production correlating with aggregation of pigment nanoparticles and product brand but not with the polycyclic aromatic hydrocarbon content.
Høgsberg T; Jacobsen NR; Clausen PA; Serup J
Exp Dermatol; 2013 Jul; 22(7):464-9. PubMed ID: 23800057
[TBL] [Abstract][Full Text] [Related]
16. In vitro assessment of skin sensitization, photosensitization and phototoxicity potential of commercial glyphosate-containing formulations.
de Ávila RI; Teixeira GC; Veloso DFMC; Moreira LC; Lima EM; Valadares MC
Toxicol In Vitro; 2017 Dec; 45(Pt 3):386-392. PubMed ID: 28389279
[TBL] [Abstract][Full Text] [Related]
17. Skin phototoxicity of cosmetic formulations containing photounstable and photostable UV-filters and vitamin A palmitate.
Gaspar LR; Tharmann J; Maia Campos PM; Liebsch M
Toxicol In Vitro; 2013 Feb; 27(1):418-25. PubMed ID: 22906567
[TBL] [Abstract][Full Text] [Related]
18. In vitro alternatives and phototoxicity testing. I. Evaluation of in vitro phototoxicity assays.
Okamoto Y; Ryu A; Ohkoshi K
Altern Lab Anim; 1999; 27(4):639-64. PubMed ID: 25487860
[TBL] [Abstract][Full Text] [Related]
19. Tattoo inks contain polycyclic aromatic hydrocarbons that additionally generate deleterious singlet oxygen.
Regensburger J; Lehner K; Maisch T; Vasold R; Santarelli F; Engel E; Gollmer A; König B; Landthaler M; Bäumler W
Exp Dermatol; 2010 Aug; 19(8):e275-81. PubMed ID: 20545755
[TBL] [Abstract][Full Text] [Related]
20. The purity of tattoo inks, screening substances of high concern.
Desmedt B; Vanhamme M; Deconinck E
Regul Toxicol Pharmacol; 2022 Mar; 129():105123. PubMed ID: 35065093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
